219 related articles for article (PubMed ID: 19434791)
1. The Birmingham Epidermolysis Bullosa Severity score: development and validation.
Moss C; Wong A; Davies P
Br J Dermatol; 2009 May; 160(5):1057-65. PubMed ID: 19434791
[TBL] [Abstract][Full Text] [Related]
2. Development, reliability, and validity of a novel Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI).
Loh CC; Kim J; Su JC; Daniel BS; Venugopal SS; Rhodes LM; Intong LR; Law MG; Murrell DF
J Am Acad Dermatol; 2014 Jan; 70(1):89-97.e1-13. PubMed ID: 24355263
[TBL] [Abstract][Full Text] [Related]
3. Hindi translation and validation of quality of life score in Indian patients with epidermolysis bullosa; and its correlation with the clinical severity assessment scores: A cross-sectional study.
Bishnoi A; Manjunath S; Kishore K; De D; Handa S; Murrell DF; Mahajan R
Indian J Dermatol Venereol Leprol; 2022; 88(2):177-183. PubMed ID: 34491666
[TBL] [Abstract][Full Text] [Related]
4. Assessment of the Timing of Milestone Clinical Events in Patients With Epidermolysis Bullosa From North America.
Feinstein JA; Jambal P; Peoples K; Lucky AW; Khuu P; Tang JY; Lara-Corrales I; Pope E; Wiss K; Hook KP; Levin LE; Morel KD; Paller AS; McCuaig CC; Powell J; Eichenfield LF; Price H; Levy ML; Schachner LA; Browning JC; Bayliss S; Jahnke M; Shwayder T; Glick SA; Bruckner AL
JAMA Dermatol; 2019 Feb; 155(2):196-203. PubMed ID: 30586139
[TBL] [Abstract][Full Text] [Related]
5. Health-related quality of life and clinical severity in people with epidermolysis bullosa - A proposal for assessing nutritional compromise by body mass index (Birmingham Epidermolysis Bullosa Severity Score).
Togo CCG; Zidório APC; Sá NM; Dutra ES
Nutr Hosp; 2024 Apr; 41(2):400-408. PubMed ID: 38149521
[TBL] [Abstract][Full Text] [Related]
6. Ophthalmologic Approach in Epidermolysis Bullosa: A Cross-Sectional Study With Phenotype-Genotype Correlations.
Mellado F; Fuentes I; Palisson F; I Vergara J; Kantor A
Cornea; 2018 Apr; 37(4):442-447. PubMed ID: 29384803
[TBL] [Abstract][Full Text] [Related]
7. Assessment of mobility, activities and pain in different subtypes of epidermolysis bullosa.
Fine JD; Johnson LB; Weiner M; Suchindran C
Clin Exp Dermatol; 2004 Mar; 29(2):122-7. PubMed ID: 14987264
[TBL] [Abstract][Full Text] [Related]
8. Eye involvement in inherited epidermolysis bullosa: experience of the National Epidermolysis Bullosa Registry.
Fine JD; Johnson LB; Weiner M; Stein A; Cash S; Deleoz J; Devries DT; Suchindran C
Am J Ophthalmol; 2004 Aug; 138(2):254-62. PubMed ID: 15289135
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology of epidermolysis bullosa in the antipodes: the Australasian Epidermolysis Bullosa Registry with a focus on Herlitz junctional epidermolysis bullosa.
Kho YC; Rhodes LM; Robertson SJ; Su J; Varigos G; Robertson I; Hogan P; Orchard D; Murrell DF
Arch Dermatol; 2010 Jun; 146(6):635-40. PubMed ID: 20566927
[TBL] [Abstract][Full Text] [Related]
10. Quality of life in epidermolysis bullosa.
Horn HM; Tidman MJ
Clin Exp Dermatol; 2002 Nov; 27(8):707-10. PubMed ID: 12472552
[TBL] [Abstract][Full Text] [Related]
11. Cause-specific risks of childhood death in inherited epidermolysis bullosa.
Fine JD; Johnson LB; Weiner M; Suchindran C
J Pediatr; 2008 Feb; 152(2):276-80. PubMed ID: 18206702
[TBL] [Abstract][Full Text] [Related]
12. A comparison study of outcome measures for epidermolysis bullosa: Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI) and the Instrument for Scoring Clinical Outcomes of Research for Epidermolysis Bullosa (iscorEB).
Rogers CL; Gibson M; Kern JS; Martin LK; Robertson SJ; Daniel BS; Su JC; Murrell OGC; Feng G; Murrell DF
JAAD Int; 2021 Mar; 2():134-152. PubMed ID: 34409361
[TBL] [Abstract][Full Text] [Related]
13. Translation, cross-cultural adaptation and validation of the Quality of Life Evaluation in Epidermolysis Bullosa instrument in Brazilian Portuguese.
Cestari T; Prati C; Menegon DB; Prado Oliveira ZN; Machado MC; Dumet J; Nakano J; Murrell DF
Int J Dermatol; 2016 Feb; 55(2):e94-9. PubMed ID: 26474322
[TBL] [Abstract][Full Text] [Related]
14. Epidermolysis bullosa and the risk of life-threatening cancers: the National EB Registry experience, 1986-2006.
Fine JD; Johnson LB; Weiner M; Li KP; Suchindran C
J Am Acad Dermatol; 2009 Feb; 60(2):203-11. PubMed ID: 19026465
[TBL] [Abstract][Full Text] [Related]
15. Instrument for scoring clinical outcome of research for epidermolysis bullosa: a consensus-generated clinical research tool.
Schwieger-Briel A; Chakkittakandiyil A; Lara-Corrales I; Aujla N; Lane AT; Lucky AW; Bruckner AL; Pope E
Pediatr Dermatol; 2015; 32(1):41-52. PubMed ID: 24650374
[TBL] [Abstract][Full Text] [Related]
16. Epidermolysis Bullosa Oropharyngeal Severity (EBOS) score: a multicenter development and reliability assessment.
Fortuna G; Chainani-Wu N; Lozada-Nur F; Aria M; Cepeda-Valdes R; Pollio A; Marinkovich MP; Martinez-Salazar AE; Mignogna MD; Bruckner AL; Salas-Alanís JC
J Am Acad Dermatol; 2013 Jan; 68(1):83-92. PubMed ID: 22575158
[TBL] [Abstract][Full Text] [Related]
17. Birmingham epidermolysis severity score and vitamin D status are associated with low BMD in children with epidermolysis bullosa.
Rodari G; Guez S; Manzoni F; Chalouhi KK; Profka E; Bergamaschi S; Salera S; Tadini G; Ulivieri FM; Spada A; Giavoli C; Esposito S
Osteoporos Int; 2017 Apr; 28(4):1385-1392. PubMed ID: 28012019
[TBL] [Abstract][Full Text] [Related]
18. Impact of inherited epidermolysis bullosa on parental interpersonal relationships, marital status and family size.
Fine JD; Johnson LB; Weiner M; Suchindran C
Br J Dermatol; 2005 May; 152(5):1009-14. PubMed ID: 15888161
[TBL] [Abstract][Full Text] [Related]
19. Graftskin therapy in epidermolysis bullosa.
Fivenson DP; Scherschun L; Choucair M; Kukuruga D; Young J; Shwayder T
J Am Acad Dermatol; 2003 Jun; 48(6):886-92. PubMed ID: 12789180
[TBL] [Abstract][Full Text] [Related]
20. Inherited epidermolysis bullosa and the risk of death from renal disease: experience of the National Epidermolysis Bullosa Registry.
Fine JD; Johnson LB; Weiner M; Stein A; Cash S; DeLeoz J; Devries DT; Suchindran C;
Am J Kidney Dis; 2004 Oct; 44(4):651-60. PubMed ID: 15384016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
